Robert Jones

22PUBLICATIONS
162CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples cultural determinants of healthPsychophysiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Sep 19, 2025
Accuracy of glomerular filtration rate estimates among patients with cancer.

Jennifer S Lees, Edouard L Fu, Anne-Laure Faucon

|Jul 28, 2025
Nivolumab and Ipilimumab for Metastatic Castration-Resistant Prostate Cancer With an Immunogenic Signature: The Multicenter, Two-Cohort, Phase II NEPTUNES Study.

Gianmarco Leone, Yien Ning Sophia Wong, Robert J Jones

|Sep 09, 2024
Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT.

Fiona Collinson, Kara-Louise Royle, Jayne Swain

|Aug 12, 2024
Pembrolizumab plus enzalutamide for metastatic castration-resistant prostate cancer progressing on enzalutamide: cohorts 4 and 5 of the phase 2 KEYNOTE-199 study.

Julie N Graff, Christopher J Hoimes, Winald R Gerritsen

|Jul 22, 2024
Optimising the use of the prostate- specific antigen blood test in asymptomatic men for early prostate cancer detection in primary care: report from a UK clinical consensus.

Thomas A Harding, Richard M Martin, Samuel Wd Merriel

|Jun 24, 2024
Reply to P. de Boissieu et al.

Alison Birtle, Robert Jones, Fay H Cafferty

Pageof 4

Frequent Collaborators

7 joint publications

Alison Jane Birtle

5 joint publications

Nicholas D James

5 joint publications

David Matheson

5 joint publications

Matthew R Sydes